Letter to the editor concerning the article 'Safety of vaccines administration in hereditary fructose intolerance'
- PMID: 33653220
- PMCID: PMC8475572
- DOI: 10.1080/21645515.2021.1891816
Letter to the editor concerning the article 'Safety of vaccines administration in hereditary fructose intolerance'
Abstract
The most important approach for the management of hereditary fructose intolerance is a strict avoidance of fructose, sucrose and sorbitol from the diet and medications. A safe threshold of 2.4 mg/kg/dose was recently established by the Instituto Superiore di Sanità of Italy for both oral and parenteral routes, thus shouldering a safe administration of a majority of vaccines in these patients. This would not include, Rotarix® pre-established oral suspension and Rotateq® vaccines, which are indeed contraindicated. Moreover, Rotarix® white powder and solvent for oral suspension would only be safely administered at a weight above 9.3 kg.Overall, these recommendations to avoid rotavirus vaccination are difficult to implement because these vaccines are given during exclusive breastfeeding, prior to fructose-containing food introduction.
Keywords: Rotavirus; hereditary fructose intolerance; safety; vaccine.
Comment in
-
Safety of Sars-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance.Hum Vaccin Immunother. 2021 Nov 2;17(11):4112-4114. doi: 10.1080/21645515.2021.1943992. Epub 2021 Jul 1. Hum Vaccin Immunother. 2021. PMID: 34197272 Free PMC article. No abstract available.
References
-
- Gallo G, Mel R, Ros E, Filia A, Ed. Guida alle controindicazioni alle vaccinazioni (aggiornamento 2018). Roma (Italy): Istituto Superiore di Sanità; 2019. (Rapporti ISTISAN 19/3).
-
- European Medicines Agency . Rotarix product information. Annex I-Summary of product characteristics. Last updated:2020. https://www.ema.europa.eu/en/documents/product-information/rotarix-epar-...
-
- Tate JE, Simonsen L, Viboud C, Steiner C, Patel MM, Curns AT, Parashar UD. Trends in intussusception hospitalizations among US infants, 1993-2004: implications for monitoring the safety of the new rotavirus vaccination program. Pediatrics. 2008;121(5):e1125–32. doi:10.1542/peds.2007-1590. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical